Instituto de Microbiología Bioquímica, Consejo Superior de Investigaciones Científicas/Universidad de Salamanca, 37007 Salamanca, Spain.
J Biol Chem. 2011 Feb 4;286(5):3484-96. doi: 10.1074/jbc.M110.174300. Epub 2010 Nov 29.
Three specific β(1,3)glucan synthase (GS) inhibitor families, papulacandins, acidic terpenoids, and echinocandins, have been analyzed in Schizosaccharomyces pombe wild-type and papulacandin-resistant cells and GS activities. Papulacandin and enfumafungin produced similar in vivo effects, different from that of echinocandins. Also, papulacandin was the strongest in vitro GS inhibitor (IC(50) 10(3)-10(4)-fold lower than with enfumafungin or pneumocandin), but caspofungin was by far the most efficient antifungal because of the following. 1) It was the only drug that affected resistant cells (minimal inhibitory concentration close to that of the wild type). 2) It was a strong inhibitor of wild-type GS (IC(50) close to that of papulacandin). 3) It was the best inhibitor of mutant GS. Moreover, caspofungin showed a special effect for two GS inhibition activities, of high and low affinity, separated by 2 log orders, with no increase in inhibition. pbr1-8 and pbr1-6 resistances are due to single substitutions in the essential Bgs4 GS, located close to the resistance hot spot 1 region described in Saccharomyces and Candida Fks mutants. Bgs4(pbr)(1-8) contains the E700V change, four residues N-terminal from hot spot 1 defining a larger resistance hot spot 1-1 of 13 amino acids. Bgs4(pbr)(1-6) contains the W760S substitution, defining a new resistance hot spot 1-2. We observed spontaneous revertants of the spherical pbr1-6 phenotype and found that an additional A914V change is involved in the recovery of the wild-type cell shape, but it maintains the resistance phenotype. A better understanding of the mechanism of action of the antifungals available should help to improve their activity and to identify new antifungal targets.
已分析了棘白菌素类化合物的三种特定β(1,3)葡聚糖合酶(GS)抑制剂家族,即:多球壳菌素、酸性萜烯和棘白菌素,在野生型裂殖酵母和多球壳菌素抗性细胞以及 GS 活性中。多球壳菌素和恩夫霉素产生了相似的体内作用,与棘白菌素不同。此外,多球壳菌素是体外最强的 GS 抑制剂(IC50 比恩夫霉素或泊沙康唑低 103-104 倍),但卡泊芬净迄今为止是最有效的抗真菌药物,原因如下。1)它是唯一一种影响抗性细胞的药物(最小抑菌浓度接近野生型)。2)它是野生型 GS 的强抑制剂(IC50 接近多球壳菌素)。3)它是突变型 GS 的最佳抑制剂。此外,卡泊芬净对两种 GS 抑制活性具有特殊作用,这两种活性的亲和力相差 2 个对数级,但抑制作用没有增加。pbr1-8 和 pbr1-6 抗性是由于基本 Bgs4 GS 中的单个取代,该基因位于与 Saccharomyces 和 Candida Fks 突变体中描述的抗性热点 1 区域附近。Bgs4(pbr)(1-8) 包含 E700V 变化,距离热点 1 四个残基 N 端,定义了 13 个氨基酸的更大的热点 1-1。Bgs4(pbr)(1-6) 包含 W760S 取代,定义了新的热点 1-2。我们观察到了 pbr1-6 球形表型的自发回复突变体,并发现 A914V 变化参与了恢复野生型细胞形态,但它保持了抗性表型。更好地了解现有抗真菌药物的作用机制应有助于提高其活性并确定新的抗真菌靶标。